1Suppliers
2Customers
1Debt Items
20Related Chains

Solventum Corporation Suppliers

TickerNameConfidenceEvidence
ACERA-SURGICAL ACERA-SURGICAL 90% In December 2025, the Company acquired Acera Surgical ("Acera"), a privately held bioscience company.

Solventum Corporation Customers

TickerNameConfidenceEvidence
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from SOLV graph: Item 1A "Risk Factors" for additional information. Management’s Discussion and Analysis of Financial Condition and Res…
TMO Thermo Fisher Scientific Inc. 72% Item 1A "Risk Factors" for additional information. Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of Solventum’s financ…

Solventum Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
SOLV-DEBT Debt stack $5.3B 90% Market cache reports total debt of $5.3B.

Solventum Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Solventum Corporation.

Solventum Corporation Ownership

HolderNameConfidenceEvidence
SOLV-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 882 tracked holders.

Solventum Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IMTX Immatics N.V. 100.00 2
CLLS Cellectis S.A. 100.00 2
MXCT MaxCyte, Inc. 100.00 2
AZTA Azenta, Inc. 100.00 2
IONS Ionis Pharmaceuticals, Inc. 100.00 2
TWST Twist Bioscience Corporation 100.00 2
ICLR ICON Public Limited Company 100.00 2
BHP BHP Group Limited 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
BHPLF BHP Group Limited 100.00 2
GH Guardant Health, Inc. 100.00 2
IDXG Interpace Biosciences, Inc. 100.00 2
VCYT Veracyte, Inc. 50.00 2
SVRA Savara Inc. 50.00 2
SUPN Supernus Pharmaceuticals, Inc. 50.00 2
RGEN Repligen Corporation 50.00 2
WAT Waters Corporation 50.00 2
DNA Ginkgo Bioworks Holdings, Inc. 50.00 2
HRMY Harmony Biosciences Holdings, Inc. 50.00 2
MEDP Medpace Holdings, Inc. 50.00 2